Société Générale — M&A Activity 2021

Mar 9, 2021

National Storage Mechanism | Additional information

RNS Number : 6313R

Societe Generale SA

09 March 2021

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1)	Société Générale S.A.
Company dealt in	Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	US$0.000304635 ordinary shares
Date of dealing	08/03/2021

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
Number	(%)	Number	(%)
(1) Relevant securities	466,922	0.36	10,786	0.01
(2) Derivatives (other than options)	1,435	0.00	7,402	0.01
(3) Options and agreements to purchase/sell	0	0.00	0	0.00
Total	*1,868,663	*1.45	18,188	0.01

* Include the holding of shares 1,400,306 on borrow products

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit USD (Note 5)
Purchase	22	229.25
Purchase	98	226.67
Purchase	2	226.67
Purchase	100	226.06
Purchase	18	229.05
Purchase	82	229.05
Purchase	100	228.91
Purchase	3	228.83
Purchase	25	226.17
Purchase	75	226.17
Purchase	1	229.32
Purchase	40	225.23
Purchase	67	228.74
Purchase	33	228.74
Purchase	6	229.05
Purchase	94	229.05
Purchase	10	225.3
Purchase	90	225.3
Purchase	18	227.3
Purchase	19	227.48
Purchase	84	227.43
Purchase	16	227.43
Purchase	20	226.7
Purchase	1	226.7
Purchase	100	228.43
Purchase	100	227.89
Purchase	92	227.06
Purchase	200	225.23
Purchase	14	229.24
Purchase	25	226.81
Purchase	75	226.8
Purchase	100	227.95
Purchase	9	230.21
Purchase	70	230.24
Purchase	30	230.23
Purchase	65	227.87
Purchase	35	227.87
Purchase	1,218	225.23
Sale	3	228.878
Sale	3	225.228
Sale	3	225.258
Sale	2	225.228
Sale	2	225.218
Sale	14	225.228
Sale	2	225.208
Sale	4	225.208
Sale	15	225.168
Sale	1	225.228
Sale	2	225.228
Sale	1	225.338
Sale	4	225.338
Sale	3	225.338
Sale	11	225.218
Sale	2	225.238
Sale	3	225.228
Sale	6	225.228
Sale	2	225.228
Sale	10	225.188
Sale	1	225.338
Sale	3	225.338
Sale	5	225.338
Sale	4	225.238
Sale	1	225.17
Sale	191	225.23
Sale	2	225.23
Sale	16	228.93
Sale	205	225.23
Sale	1,216	225.23
Total Purchases	3,157
Total Sales	1,737

(b)      Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit USD (Note 5)

(c)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any 

other person relating to the voting rights of any relevant securities under any option referred to on this 

form or relating to the voting rights or future acquisition or disposal of any relevant securities to which 

any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            No

Date of disclosure	09/03/2021
Contact name	Société Générale - Disclosure team
Telephone number	+33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEFIFVAVVIAIIL